Sun Pharma's 2 US arms to pay USD 85 mn in settlement pacts over antritrust litigation

Under the terms of the settlement agreements, the subsidiaries will make an aggregate payment amounting to a combined total of USD 85 million in exchange for a full release of all claims asserted against them in the direct purchaser action by the settlement class members, it added.

from Markets-Economic Times https://ift.tt/2YjVBQD